Log In
BCIQ
Print this Print this
 

Elucigene FH20

  Manage Alerts
Collapse Summary General Information
Company Hologic Inc.
Descriptionin vitro genotyping assay for 20 genetic mutations to screen for familial hypercholesterolemia (FH)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationMetabolic, Diagnostic
Indication DetailsDiagnose familial hypercholesterolemia (FH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today